Dimensional Fund Advisors LP raised its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 18.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,182,729 shares of the company's stock after acquiring an additional 486,395 shares during the period. Dimensional Fund Advisors LP owned approximately 3.43% of Acadia Healthcare worth $126,189,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Marshall Wace LLP grew its holdings in Acadia Healthcare by 50.8% during the 4th quarter. Marshall Wace LLP now owns 380,391 shares of the company's stock valued at $15,083,000 after purchasing an additional 128,142 shares during the last quarter. Jump Financial LLC bought a new position in shares of Acadia Healthcare during the fourth quarter valued at approximately $4,909,000. XTX Topco Ltd raised its holdings in shares of Acadia Healthcare by 38.2% in the fourth quarter. XTX Topco Ltd now owns 13,576 shares of the company's stock worth $538,000 after buying an additional 3,753 shares during the period. Mariner LLC lifted its stake in shares of Acadia Healthcare by 88.7% during the 4th quarter. Mariner LLC now owns 16,638 shares of the company's stock worth $660,000 after acquiring an additional 7,823 shares during the last quarter. Finally, Barclays PLC boosted its holdings in Acadia Healthcare by 32.9% during the 4th quarter. Barclays PLC now owns 146,208 shares of the company's stock valued at $5,796,000 after acquiring an additional 36,189 shares during the period.
Wall Street Analyst Weigh In
ACHC has been the subject of several research analyst reports. Barclays downgraded Acadia Healthcare from an "overweight" rating to an "equal weight" rating and decreased their target price for the stock from $43.00 to $35.00 in a research report on Friday, February 28th. Mizuho decreased their price objective on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a report on Tuesday, March 25th. KeyCorp dropped their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research note on Monday, March 3rd. Guggenheim began coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They set a "buy" rating and a $36.00 price target for the company. Finally, StockNews.com lowered Acadia Healthcare from a "hold" rating to a "sell" rating in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $50.39.
Check Out Our Latest Analysis on Acadia Healthcare
Acadia Healthcare Stock Performance
Shares of NASDAQ:ACHC opened at $22.15 on Friday. The firm has a 50 day moving average of $29.42 and a 200 day moving average of $38.61. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $2.04 billion, a price-to-earnings ratio of 7.26, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41.
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
